Clinical Research Support
Office for Human Research Studies (OHRS)
Letter from OHRS for Sponsors Outlining DF/HCC IRB Procedures
2) Letter from OPRS for Sponsors Outlining DF/HCC IRB Procedures
The Federal Policy (Common Rule) for the Protection of Human Subjects requires that each institution "engaged" in federally-supported human subject research have an "Assurance" of protection for human subjects. The Assurance formalizes the institution's commitment to protect human subjects. The DFCI assurance number is FWA00001121 and is valid through 2008.
Click to Open Letter from OPRS for Sponsors Outlining DF/HCC IRB Procedures *REVISED September 04, 2008
DFCI IRBs (Institutional Review Board) are registered with the OHRP (Office for the Human Research Protection) as well. At the present time, registration is required only for IRBs and IECs (Institutional Ethics Committees) designated under an OHRP Federalwide Assurance of Protection for Human Subjects. IRB Registration is not currently required by the FDA (Federal Drug Administration.) DFCI FWA & IRB registration numbers are:
- FWA00001121 Dana-Farber Cancer Inst BOSTON MASSACHUSETTS
- IRB00000052 DANA-FARBER CANCER INST IRB#1 - PANEL 'A' of IORG0000035 - BOSTON, MA
- IRB00000753 DANA-FARBER CANCER INST IRB#2 - PANEL 'B' of IORG0000035 - BOSTON, MA
- IRB00001186 DANA-FARBER CANCER INST IRB#3 - PANEL 'C' of IORG0000035 - BOSTON, MA
- IRB00003340 DANA-FARBER CANCER INST IRB#4 - PANEL 'D' of IORG0000035 - BOSTON, MA
- TIRB00005504 DANA-FARBER CANCER INST IRB#5 - PANEL 'E' of IORG0000035 - BOSTON, MA
- IRB00006224 DANA-FARBER CANCER INST IRB#6 - PANEL 'F' of IORG0000035 - BOSTON, MA
- Quality Assurance Office for Clinical Trials (QACT)
- Clinical Research Unit (CRU)
- Clinical Trials Education Office (CTEO)
- Protocol Review and Monitoring System (PRMS)
